MedPAC Votes For Draft Recommendations To Curb Part B Drug Prices

By John Wilkerson / April 12, 2017 at 7:30 PM
After two years of consideration, congressional Medicare advisers voted April 6 for a package of draft recommendations aimed at curbing the rise of drug prices covered by Part B. While commissioners stuck to the structure of the policies they discussed in a recent meeting, there were some changes aimed at avoiding unintended consequences. The vote was unanimous in favor of the recommendations, but a few Medicare Payment Advisory Commission members said they dislike some of the policies, and the option...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.